0001567619-21-013956.txt : 20210726 0001567619-21-013956.hdr.sgml : 20210726 20210726124732 ACCESSION NUMBER: 0001567619-21-013956 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210726 DATE AS OF CHANGE: 20210726 EFFECTIVENESS DATE: 20210726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Manistee Therapeutics, Inc. CENTRAL INDEX KEY: 0001874367 IRS NUMBER: 863208521 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-407718 FILM NUMBER: 211113435 BUSINESS ADDRESS: STREET 1: 84 BARNES HILL ROAD CITY: CONCORD STATE: MA ZIP: 01742 BUSINESS PHONE: 617-538-7105 MAIL ADDRESS: STREET 1: 84 BARNES HILL ROAD CITY: CONCORD STATE: MA ZIP: 01742 D 1 primary_doc.xml X0708 D LIVE 0001874367 Manistee Therapeutics, Inc. 84 BARNES HILL ROAD CONCORD MA MASSACHUSETTS 01742 617-538-7105 DELAWARE None None Corporation true 2021 Robert L. Bratzler, Ph.D. 84 Barnes Hill Road Concord MA MASSACHUSETTS 01742 Executive Officer Director Stephen Bruso 84 Barnes Hill Road Concord MA MASSACHUSETTS 01742 Director Bradford J. Shingleton, M.D 84 Barnes Hill Road Concord MA MASSACHUSETTS 01742 Executive Officer Director Other Decline to Disclose 06b false 2021-07-13 false true false 0 9500000 9500000 0 false 6 0 0 0 false Manistee Therapeutics, Inc. /s/ Robert L. Bratzler, Ph.D. Robert L. Bratzler, Ph.D. President & Chief Executive Officer 2021-07-26